Filing Details
- Accession Number:
- 0001628280-25-029368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-04 16:40:24
- Reporting Period:
- 2025-06-02
- Filing Date:
- 2025-06-04
- Accepted Time:
- 2025-06-04 16:40:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402051 | William Lewis | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chair And Ceo | Yes | Yes | No | No |
Transaction Summary
Sold: | 12,302 shares | Avg. Price: $71.39 | Total Value: $878,292.20 |
Number of Shares After Transactions: | 308,758 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-02 | 6,830 | $10.85 | 240,754 | No | 4 | M | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-06-02 | 1,000 | $70.23 | 239,754 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-06-02 | 4,400 | $71.35 | 235,354 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-06-02 | 1,430 | $71.94 | 233,924 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Common Stock | Disposition | 2025-06-03 | 5,472 | $71.50 | 308,758 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2025-06-02 | 6,830 | $0.00 | 6,830 | $10.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
157,160 | 2026-05-19 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 50,500 | Indirect | By the William Lewis Family Legacy Trust |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 1,000 shares sold at prices ranging from $69.59 to $70.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 4,400 shares sold at prices ranging from $70.67 to $71.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 1,430 shares sold at prices ranging from $71.67 to $72.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
- The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.